Science
Mechanism of Obesity-Related Cellular Dysfunction
Mellicell's Pipeline Development
Mellicell.com is a platform that provides an innovative pipeline for cell therapy development. Its approach integrates advanced technologies to streamline the process of developing cell-based therapies. The focus is on enhancing efficiency, scalability, and safety throughout the pipeline, from cell selection and modification to manufacturing and delivery. Mellicell.com aims to accelerate the translation of promising cell therapies from the lab to clinical applications, ultimately benefiting patients worldwide.
MelliCell develops drug therapies that shrink fat cells in order to treat diabetes and other metabolic diseases like obesity
Copyright © 2024 MelliCell. All Rights Reserved.